206 related articles for article (PubMed ID: 33427523)
1. Microneedle Systems for Vaccine Delivery: the story so far.
Hossain MK; Ahmed T; Bhusal P; Subedi RK; Salahshoori I; Soltani M; Hassanzadeganroudsari M
Expert Rev Vaccines; 2020 Dec; 19(12):1153-1166. PubMed ID: 33427523
[TBL] [Abstract][Full Text] [Related]
2. Microneedles for vaccine delivery: challenges and future perspectives.
Shin CI; Jeong SD; Rejinold NS; Kim YC
Ther Deliv; 2017 Jun; 8(6):447-460. PubMed ID: 28530151
[TBL] [Abstract][Full Text] [Related]
3. Microneedle arrays for vaccine delivery: the possibilities, challenges and use of nanoparticles as a combinatorial approach for enhanced vaccine immunogenicity.
Rodgers AM; Cordeiro AS; Kissenpfennig A; Donnelly RF
Expert Opin Drug Deliv; 2018 Sep; 15(9):851-867. PubMed ID: 30051726
[TBL] [Abstract][Full Text] [Related]
4. Dissolving Microneedle Patches for Dermal Vaccination.
Leone M; Mönkäre J; Bouwstra JA; Kersten G
Pharm Res; 2017 Nov; 34(11):2223-2240. PubMed ID: 28718050
[TBL] [Abstract][Full Text] [Related]
5. Microneedle Patches as Drug and Vaccine Delivery Platform.
Li J; Zeng M; Shan H; Tong C
Curr Med Chem; 2017; 24(22):2413-2422. PubMed ID: 28552053
[TBL] [Abstract][Full Text] [Related]
6. Microneedle technology for potential SARS-CoV-2 vaccine delivery.
McNamee M; Wong S; Guy O; Sharma S
Expert Opin Drug Deliv; 2023 Jun; 20(6):799-814. PubMed ID: 37128730
[TBL] [Abstract][Full Text] [Related]
7. Dissolving Microneedle Arrays for Transdermal Delivery of Amphiphilic Vaccines.
An M; Liu H
Small; 2017 Jul; 13(26):. PubMed ID: 28544329
[TBL] [Abstract][Full Text] [Related]
8. Microneedle Technology: An Insight into Recent Advancements and Future Trends in Drug and Vaccine Delivery.
Gupta J; Gupta R; Vanshita
Assay Drug Dev Technol; 2021; 19(2):97-114. PubMed ID: 33297823
[No Abstract] [Full Text] [Related]
9. The success of microneedle-mediated vaccine delivery into skin.
Marshall S; Sahm LJ; Moore AC
Hum Vaccin Immunother; 2016 Nov; 12(11):2975-2983. PubMed ID: 27050528
[TBL] [Abstract][Full Text] [Related]
10. Laser-engineered dissolving microneedle arrays for protein delivery: potential for enhanced intradermal vaccination.
McCrudden MT; Torrisi BM; Al-Zahrani S; McCrudden CM; Zaric M; Scott CJ; Kissenpfennig A; McCarthy HO; Donnelly RF
J Pharm Pharmacol; 2015 Mar; 67(3):409-25. PubMed ID: 24673568
[TBL] [Abstract][Full Text] [Related]
11. Microneedle-mediated delivery of viral vectored vaccines.
Zaric M; Ibarzo Yus B; Kalcheva PP; Klavinskis LS
Expert Opin Drug Deliv; 2017 Oct; 14(10):1177-1187. PubMed ID: 27591122
[TBL] [Abstract][Full Text] [Related]
12. Microneedle Transdermal Drug Delivery Systems for Allergen-Specific Immunotherapy, Skin Disease Treatment, and Vaccine Development.
Park CO; Kim HL; Park JW
Yonsei Med J; 2022 Oct; 63(10):881-891. PubMed ID: 36168240
[TBL] [Abstract][Full Text] [Related]
13. Progress in microneedle array patch (MAP) for vaccine delivery.
Nguyen TT; Oh Y; Kim Y; Shin Y; Baek SK; Park JH
Hum Vaccin Immunother; 2021 Jan; 17(1):316-327. PubMed ID: 32667239
[TBL] [Abstract][Full Text] [Related]
14. Microneedle-Based Vaccine Delivery: Review of an Emerging Technology.
Mansoor I; Eassa HA; Mohammed KHA; Abd El-Fattah MA; Abdo MH; Rashad E; Eassa HA; Saleh A; Amin OM; Nounou MI; Ghoneim O
AAPS PharmSciTech; 2022 Apr; 23(4):103. PubMed ID: 35381906
[TBL] [Abstract][Full Text] [Related]
15. Microneedle-mediated vaccine delivery: harnessing cutaneous immunobiology to improve efficacy.
Al-Zahrani S; Zaric M; McCrudden C; Scott C; Kissenpfennig A; Donnelly RF
Expert Opin Drug Deliv; 2012 May; 9(5):541-50. PubMed ID: 22475249
[TBL] [Abstract][Full Text] [Related]
16. Development of novel double-decker microneedle patches for transcutaneous vaccine delivery.
Ono A; Azukizawa H; Ito S; Nakamura Y; Asada H; Quan YS; Kamiyama F; Katayama I; Hirobe S; Okada N
Int J Pharm; 2017 Oct; 532(1):374-383. PubMed ID: 28855138
[TBL] [Abstract][Full Text] [Related]
17. Microneedles as an alternative technology for transdermal drug delivery systems: a patent review.
Queiroz MLB; Shanmugam S; Santos LNS; Campos CA; Santos AM; Batista MS; Araújo AAS; Serafini MR
Expert Opin Ther Pat; 2020 Jun; 30(6):433-452. PubMed ID: 32164470
[No Abstract] [Full Text] [Related]
18. DNA vaccination via RALA nanoparticles in a microneedle delivery system induces a potent immune response against the endogenous prostate cancer stem cell antigen.
Cole G; Ali AA; McErlean E; Mulholland EJ; Short A; McCrudden CM; McCaffrey J; Robson T; Kett VL; Coulter JA; Dunne NJ; Donnelly RF; McCarthy HO
Acta Biomater; 2019 Sep; 96():480-490. PubMed ID: 31299353
[TBL] [Abstract][Full Text] [Related]
19. Biocompatible Mater Constructed Microneedle Arrays as a Novel Vaccine Adjuvant- Delivery System for Cutaneous and Mucosal Vaccination.
Wang T; Wang N
Curr Pharm Des; 2015; 21(36):5245-55. PubMed ID: 26412356
[TBL] [Abstract][Full Text] [Related]
20. Microneedle delivery: clinical studies and emerging medical applications.
Pettis RJ; Harvey AJ
Ther Deliv; 2012 Mar; 3(3):357-71. PubMed ID: 22833995
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
